The conclusions of this study are as follows.Rab proteins (i.e., Rab9 and Rab42) promote tumour progression by influencing trafficking and interacting with other proteins and pathways (e.g., p40, E2F1, immune tolerance, and checkpoint proteins). The gene discussed is RAB9A; the disease is neoplasm.